Medicare Coverage of Weight Loss Drugs
Medicare will cover GLP-1 weight loss drugs (like Ozempic and Wegovy) for the first time starting July 1, 2026, with a $50 monthly copay for eligible beneficiaries. This represents a major policy shift affecting millions of Medicare recipients.
- Status
- Backlog
- Category
- Healthcare
- Geographic Scope
- National
- Salience Score
- 4
Timeline
- : Issue automatically created from AI pipeline analysis. Medicare will cover GLP-1 weight loss drugs (like Ozempic and Wegovy) for the first time starting July 1, 2026, with a $50 monthly copay for eligible beneficiaries. This represents a major policy shift affecting millions of Medicare recipients.